{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2024,10,21]],"date-time":"2024-10-21T12:40:33Z","timestamp":1729514433566,"version":"3.28.0"},"reference-count":60,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2024,10,21]],"date-time":"2024-10-21T00:00:00Z","timestamp":1729468800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2024,10,21]],"date-time":"2024-10-21T00:00:00Z","timestamp":1729468800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Int J Emerg Med"],"DOI":"10.1186\/s12245-024-00750-x","type":"journal-article","created":{"date-parts":[[2024,10,21]],"date-time":"2024-10-21T12:02:42Z","timestamp":1729512162000},"update-policy":"http:\/\/dx.doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Diagnostic and therapeutic challenges in rapidly progressing cardiac amyloidosis: a literature review based on case report"],"prefix":"10.1186","volume":"17","author":[{"given":"Nahid","family":"Senobari","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Roozbeh","family":"Nazari","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Pouya","family":"Ebrahimi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hamidreza","family":"Soleimani","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Maryam","family":"Taheri","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kaveh","family":"Hosseini","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Homa","family":"Taheri","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Robert J.","family":"Siegel","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2024,10,21]]},"reference":[{"key":"750_CR1","unstructured":"Shams PAI, Cardiac Amyloidosis. [Updated 2023 Jul 30]. In: StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing; 2024 Jan-. 2024."},{"issue":"1","key":"750_CR2","doi-asserted-by":"publisher","first-page":"10","DOI":"10.1159\/000444206","volume":"2","author":"HL Nienhuis","year":"2016","unstructured":"Nienhuis HL, Bijzet J, Hazenberg BP. The prevalence and management of systemic amyloidosis in Western Countries. Kidney Dis (Basel). 2016;2(1):10\u20139.","journal-title":"Kidney Dis (Basel)"},{"issue":"1","key":"750_CR3","doi-asserted-by":"publisher","first-page":"10","DOI":"10.1016\/j.tcm.2017.07.004","volume":"28","author":"OK Siddiqi","year":"2018","unstructured":"Siddiqi OK, Ruberg FL. Cardiac amyloidosis: an update on pathophysiology, diagnosis, and treatment. Trends Cardiovasc Med. 2018;28(1):10\u201321.","journal-title":"Trends Cardiovasc Med"},{"issue":"1","key":"750_CR4","doi-asserted-by":"publisher","first-page":"e7","DOI":"10.1161\/CIR.0000000000000792","volume":"142","author":"MM Kittleson","year":"2020","unstructured":"Kittleson MM, Maurer MS, Ambardekar AV, Bullock-Palmer RP, Chang PP, Eisen HJ, et al. Cardiac amyloidosis: evolving diagnosis and management: a Scientific Statement from the American Heart Association. Circulation. 2020;142(1):e7\u201322.","journal-title":"Circulation"},{"issue":"12","key":"750_CR5","doi-asserted-by":"publisher","first-page":"1323","DOI":"10.1016\/j.jacc.2016.06.053","volume":"68","author":"RH Falk","year":"2016","unstructured":"Falk RH, Alexander KM, Liao R, Dorbala S. AL (Light-Chain) Cardiac Amyloidosis: a review of diagnosis and therapy. J Am Coll Cardiol. 2016;68(12):1323\u201341.","journal-title":"J Am Coll Cardiol"},{"issue":"4","key":"750_CR6","doi-asserted-by":"publisher","first-page":"1326","DOI":"10.1016\/0006-291X(81)90764-6","volume":"99","author":"M Skinner","year":"1981","unstructured":"Skinner M, Cohen AS. The prealbumin nature of the amyloid protein in familial amyloid polyneuropathy (FAP)-swedish variety. Biochem Biophys Res Commun. 1981;99(4):1326\u201332.","journal-title":"Biochem Biophys Res Commun"},{"issue":"9","key":"750_CR7","doi-asserted-by":"publisher","first-page":"4499","DOI":"10.1073\/pnas.75.9.4499","volume":"75","author":"PP Costa","year":"1978","unstructured":"Costa PP, Figueira AS, Bravo FR. Amyloid fibril protein related to prealbumin in familial amyloidotic polyneuropathy. Proc Natl Acad Sci U S A. 1978;75(9):4499\u2013503.","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"10","key":"750_CR8","doi-asserted-by":"publisher","first-page":"1286","DOI":"10.1161\/CIRCULATIONAHA.111.078915","volume":"126","author":"FL Ruberg","year":"2012","unstructured":"Ruberg FL, Berk JL. Transthyretin (TTR) cardiac amyloidosis. Circulation. 2012;126(10):1286\u2013300.","journal-title":"Circulation"},{"issue":"Suppl 2","key":"750_CR9","doi-asserted-by":"publisher","first-page":"s30","DOI":"10.7861\/clinmedicine.18-2-s30","volume":"18","author":"A Martinez-Naharro","year":"2018","unstructured":"Martinez-Naharro A, Hawkins PN, Fontana M. Cardiac amyloidosis. Clin Med (Lond). 2018;18(Suppl 2):s30\u20135.","journal-title":"Clin Med (Lond)"},{"issue":"1","key":"750_CR10","doi-asserted-by":"publisher","first-page":"43","DOI":"10.1186\/s12872-021-01856-3","volume":"21","author":"C Lei","year":"2021","unstructured":"Lei C, Zhu X, Hsi DH, Wang J, Zuo L, Ta S, et al. Predictors of cardiac involvement and survival in patients with primary systemic light-chain amyloidosis: roles of the clinical, chemical, and 3-D speckle tracking echocardiography parameters. BMC Cardiovasc Disord. 2021;21(1):43.","journal-title":"BMC Cardiovasc Disord"},{"key":"750_CR11","doi-asserted-by":"publisher","first-page":"138","DOI":"10.1016\/j.ijcard.2019.12.063","volume":"304","author":"B Ladefoged","year":"2020","unstructured":"Ladefoged B, Dybro A, Povlsen JA, Vase H, Clemmensen TS, Poulsen SH. Diagnostic delay in wild type transthyretin cardiac amyloidosis - A clinical challenge. Int J Cardiol. 2020;304:138\u201343.","journal-title":"Int J Cardiol"},{"issue":"12","key":"750_CR12","doi-asserted-by":"publisher","first-page":"101366","DOI":"10.1016\/j.cpcardiol.2022.101366","volume":"47","author":"I Pour-Ghaz","year":"2022","unstructured":"Pour-Ghaz I, Bath A, Kayali S, Alkhatib D, Yedlapati N, Rhea I, et al. A review of Cardiac Amyloidosis: presentation, diagnosis, and treatment. Curr Probl Cardiol. 2022;47(12):101366.","journal-title":"Curr Probl Cardiol"},{"issue":"7","key":"750_CR13","doi-asserted-by":"publisher","first-page":"1227","DOI":"10.1002\/ejhf.2533","volume":"24","author":"A Porcari","year":"2022","unstructured":"Porcari A, Rossi M, Cappelli F, Canepa M, Musumeci B, Cipriani A, et al. Incidence and risk factors for pacemaker implantation in light-chain and transthyretin cardiac amyloidosis. Eur J Heart Fail. 2022;24(7):1227\u201336.","journal-title":"Eur J Heart Fail"},{"key":"750_CR14","unstructured":"Brown KN, Pendela VS, Ahmed I, Diaz RR. Restrictive cardiomyopathy. StatPearls. Treasure Island (FL): StatPearls Publishing Copyright \u00a9 2024. StatPearls Publishing LLC.; 2024."},{"key":"750_CR15","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/1750-1172-7-1","volume":"7","author":"E Desport","year":"2012","unstructured":"Desport E, Bridoux F, Sirac C, Delbes S, Bender S, Fernandez B, et al. Al Amyloidosis Orphanet J rare Dis. 2012;7:1\u201313.","journal-title":"Al Amyloidosis Orphanet J rare Dis"},{"issue":"1","key":"750_CR16","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1097\/CRD.0b013e3181bdba8f","volume":"18","author":"HV Desai","year":"2010","unstructured":"Desai HV, Aronow WS, Peterson SJ, Frishman WH. Cardiac amyloidosis: approaches to diagnosis and management. Cardiol Rev. 2010;18(1):1\u201311.","journal-title":"Cardiol Rev"},{"issue":"9","key":"750_CR17","doi-asserted-by":"publisher","first-page":"673","DOI":"10.1080\/14779072.2019.1662723","volume":"17","author":"B Di Giovanni","year":"2019","unstructured":"Di Giovanni B, Gustafson D, Delgado DH. Amyloid transthyretin cardiac amyloidosis: diagnosis and management. Expert Rev Cardiovasc Ther. 2019;17(9):673\u201381.","journal-title":"Expert Rev Cardiovasc Ther"},{"issue":"3","key":"750_CR18","doi-asserted-by":"publisher","first-page":"271","DOI":"10.1111\/anec.12036","volume":"18","author":"R Mussinelli","year":"2013","unstructured":"Mussinelli R, Salinaro F, Alogna A, Boldrini M, Raimondi A, Musca F, et al. Diagnostic and prognostic value of low QRS voltages in cardiac AL amyloidosis. Ann Noninvasive Electrocardiol. 2013;18(3):271\u201380.","journal-title":"Ann Noninvasive Electrocardiol"},{"issue":"4","key":"750_CR19","doi-asserted-by":"publisher","first-page":"458","DOI":"10.1016\/j.jaccao.2022.08.007","volume":"4","author":"A Cipriani","year":"2022","unstructured":"Cipriani A, De Michieli L, Porcari A, Licchelli L, Sinigiani G, Tini G, et al. Low QRS voltages in Cardiac Amyloidosis: clinical correlates and Prognostic Value. JACC CardioOncol. 2022;4(4):458\u201370.","journal-title":"JACC CardioOncol"},{"issue":"9","key":"750_CR20","doi-asserted-by":"publisher","first-page":"108","DOI":"10.1007\/s11886-019-1180-2","volume":"21","author":"L Chacko","year":"2019","unstructured":"Chacko L, Martone R, Cappelli F, Fontana M. Cardiac amyloidosis: updates in imaging. Curr Cardiol Rep. 2019;21(9):108.","journal-title":"Curr Cardiol Rep"},{"key":"750_CR21","doi-asserted-by":"crossref","unstructured":"Barberato SH, Beck ALS, Hotta VT, Rassi DC. A critical review of echocardiographic findings for diagnosing Cardiac Amyloidosis. Int J Cardiovasc Sci. 2024;37.","DOI":"10.36660\/ijcs.20240047"},{"issue":"3","key":"750_CR22","doi-asserted-by":"publisher","first-page":"e005588","DOI":"10.1161\/CIRCIMAGING.116.005588","volume":"10","author":"ED Pagourelias","year":"2017","unstructured":"Pagourelias ED, Mirea O, Duchenne J, Van Cleemput J, Delforge M, Bogaert J, et al. Echo parameters for Differential diagnosis in Cardiac Amyloidosis: a Head-to-Head comparison of deformation and nondeformation parameters. Circ Cardiovasc Imaging. 2017;10(3):e005588.","journal-title":"Circ Cardiovasc Imaging"},{"issue":"16","key":"750_CR23","doi-asserted-by":"publisher","first-page":"1554","DOI":"10.1093\/eurheartj\/ehab072","volume":"42","author":"P Garcia-Pavia","year":"2021","unstructured":"Garcia-Pavia P, Rapezzi C, Adler Y, Arad M, Basso C, Brucato A, et al. Diagnosis and treatment of cardiac amyloidosis: a position statement of the ESC Working Group on Myocardial and Pericardial diseases. Eur Heart J. 2021;42(16):1554\u201368.","journal-title":"Eur Heart J"},{"issue":"9","key":"750_CR24","doi-asserted-by":"publisher","first-page":"A31","DOI":"10.1016\/j.echo.2022.06.006","volume":"35","author":"SAM Cuddy","year":"2022","unstructured":"Cuddy SAM, Chetrit M, Jankowski M, Desai M, Falk RH, Weiner RB, et al. Practical points for Echocardiography in Cardiac Amyloidosis. J Am Soc Echocardiogr. 2022;35(9):A31\u201340.","journal-title":"J Am Soc Echocardiogr"},{"issue":"2","key":"750_CR25","doi-asserted-by":"publisher","first-page":"253","DOI":"10.1111\/j.1540-8175.1991.tb01395.x","volume":"8","author":"E Picano","year":"1991","unstructured":"Picano E, Pinamonti B, Ferdeghini EM, Landini L, Slavich G, Orlandini A, et al. Two-dimensional echocardiography in myocardial amyloidosis. Echocardiography. 1991;8(2):253\u20139.","journal-title":"Echocardiography"},{"issue":"2","key":"750_CR26","doi-asserted-by":"publisher","first-page":"117","DOI":"10.1007\/s10741-015-9480-0","volume":"20","author":"C Rapezzi","year":"2015","unstructured":"Rapezzi C, Lorenzini M, Longhi S, Milandri A, Gagliardi C, Bartolomei I, et al. Cardiac amyloidosis: the great pretender. Heart Fail Rev. 2015;20(2):117\u201324.","journal-title":"Heart Fail Rev"},{"issue":"4","key":"750_CR27","doi-asserted-by":"publisher","first-page":"909","DOI":"10.1016\/j.jcmg.2019.10.011","volume":"13","author":"M Boldrini","year":"2020","unstructured":"Boldrini M, Cappelli F, Chacko L, Restrepo-Cordoba MA, Lopez-Sainz A, Giannoni A, et al. Multiparametric Echocardiography scores for the diagnosis of Cardiac Amyloidosis. JACC Cardiovasc Imaging. 2020;13(4):909\u201320.","journal-title":"JACC Cardiovasc Imaging"},{"issue":"3","key":"750_CR28","doi-asserted-by":"publisher","first-page":"561","DOI":"10.36660\/abc.20210718","volume":"117","author":"MV Sim\u00f5es","year":"2021","unstructured":"Sim\u00f5es MV, Fernandes F, Marcondes-Braga FG, Scheinberg P, Correia EB, Rohde LEP, et al. Position Statement on diagnosis and treatment of Cardiac amyloidosis \u2013\u20092021. Arq Bras Cardiol. 2021;117(3):561\u201398.","journal-title":"Arq Bras Cardiol"},{"issue":"9","key":"750_CR29","doi-asserted-by":"publisher","first-page":"1493","DOI":"10.1002\/ejhf.2997","volume":"25","author":"B Moura","year":"2023","unstructured":"Moura B, Aimo A, Al-Mohammad A, Keramida K, Ben Gal T, Dorbala S, et al. Diagnosis and management of patients with left ventricular hypertrophy: role of multimodality cardiac imaging. A scientific statement of the Heart Failure Association of the European Society of Cardiology. Eur J Heart Fail. 2023;25(9):1493\u2013506.","journal-title":"Eur J Heart Fail"},{"issue":"1","key":"750_CR30","doi-asserted-by":"publisher","first-page":"65","DOI":"10.1007\/s10741-023-10350-1","volume":"29","author":"A Aimo","year":"2024","unstructured":"Aimo A, Camerini L, Fabiani I, Morfino P, Panichella G, Barison A, et al. Valvular heart disease in patients with cardiac amyloidosis. Heart Fail Rev. 2024;29(1):65\u201377.","journal-title":"Heart Fail Rev"},{"issue":"25 Pt A","key":"750_CR31","doi-asserted-by":"publisher","first-page":"2852","DOI":"10.1016\/j.jacc.2014.04.018","volume":"63","author":"S Coffey","year":"2014","unstructured":"Coffey S, Cox B, Williams MJ. The prevalence, incidence, progression, and risks of aortic valve sclerosis: a systematic review and meta-analysis. J Am Coll Cardiol. 2014;63(25 Pt A):2852\u201361.","journal-title":"J Am Coll Cardiol"},{"issue":"1","key":"750_CR32","doi-asserted-by":"publisher","first-page":"32","DOI":"10.1186\/s12947-019-0182-y","volume":"17","author":"G Pesk\u00f3","year":"2019","unstructured":"Pesk\u00f3 G, Jenei Z, Varga G, Apor A, V\u00e1g\u00f3 H, Czibor S, et al. Coexistence of aortic valve stenosis and cardiac amyloidosis: echocardiographic and clinical significance. Cardiovasc Ultrasound. 2019;17(1):32.","journal-title":"Cardiovasc Ultrasound"},{"issue":"29","key":"750_CR33","doi-asserted-by":"publisher","first-page":"2759","DOI":"10.1093\/eurheartj\/ehaa170","volume":"41","author":"PR Scully","year":"2020","unstructured":"Scully PR, Patel KP, Treibel TA, Thornton GD, Hughes RK, Chadalavada S, et al. Prevalence and outcome of dual aortic stenosis and cardiac amyloid pathology in patients referred for transcatheter aortic valve implantation. Eur Heart J. 2020;41(29):2759\u201367.","journal-title":"Eur Heart J"},{"issue":"6","key":"750_CR34","doi-asserted-by":"publisher","first-page":"465","DOI":"10.1016\/j.euje.2005.09.002","volume":"7","author":"F Mookadam","year":"2006","unstructured":"Mookadam F, Haley JH, Olson LJ, Cikes M, Mookadam M. Dynamic left ventricular outflow tract obstruction in senile cardiac amyloidosis. Eur J Echocardiogr. 2006;7(6):465\u20138.","journal-title":"Eur J Echocardiogr"},{"issue":"12","key":"750_CR35","doi-asserted-by":"publisher","first-page":"1313","DOI":"10.1016\/j.healun.2007.09.014","volume":"26","author":"AV Kristen","year":"2007","unstructured":"Kristen AV, Perz JB, Schonland SO, Hansen A, Hegenbart U, Sack FU, et al. Rapid progression of left ventricular wall thickness predicts mortality in cardiac light-chain amyloidosis. J Heart Lung Transpl. 2007;26(12):1313\u20139.","journal-title":"J Heart Lung Transpl"},{"issue":"4","key":"750_CR36","doi-asserted-by":"publisher","first-page":"486","DOI":"10.1016\/S0002-9149(97)00400-1","volume":"80","author":"AR Patel","year":"1997","unstructured":"Patel AR, Dubrey SW, Mendes LA, Skinner M, Cupples A, Falk RH, Davidoff R. Right ventricular dilation in primary amyloidosis: an independent predictor of survival. Am J Cardiol. 1997;80(4):486\u201392.","journal-title":"Am J Cardiol"},{"issue":"3","key":"750_CR37","doi-asserted-by":"publisher","first-page":"271","DOI":"10.1016\/j.amjms.2015.12.015","volume":"351","author":"L Zhao","year":"2016","unstructured":"Zhao L, Tian Z, Fang Q. Risk factors and Prognostic Role of Left Atrial Enlargement in patients with Cardiac Light-Chain Amyloidosis. Am J Med Sci. 2016;351(3):271\u20138.","journal-title":"Am J Med Sci"},{"issue":"1","key":"750_CR38","doi-asserted-by":"publisher","first-page":"17","DOI":"10.4103\/jcecho.jcecho_112_20","volume":"31","author":"R Licordari","year":"2021","unstructured":"Licordari R, Minutoli F, Recupero A, Campisi M, Donato R, Mazzeo A, et al. Early impairment of right ventricular morphology and function in transthyretin-related Cardiac Amyloidosis. J Cardiovasc Echogr. 2021;31(1):17\u201322.","journal-title":"J Cardiovasc Echogr"},{"issue":"1","key":"750_CR39","doi-asserted-by":"publisher","first-page":"18","DOI":"10.1080\/13506129.2017.1417121","volume":"25","author":"C Uzan","year":"2018","unstructured":"Uzan C, Lairez O, Raud-Raynier P, Garcia R, Degand B, Christiaens LP, Rehman MB. Right ventricular longitudinal strain: a tool for diagnosis and prognosis in light-chain amyloidosis. Amyloid. 2018;25(1):18\u201325.","journal-title":"Amyloid"},{"issue":"2","key":"750_CR40","first-page":"133","volume":"7","author":"JN Dungu","year":"2014","unstructured":"Dungu JN, Valencia O, Pinney JH, Gibbs SDJ, Rowczenio D, Gilbertson JA, et al. CMR-Based differentiation of AL and ATTR Cardiac Amyloidosis. JACC: Cardiovasc Imaging. 2014;7(2):133\u201342.","journal-title":"JACC: Cardiovasc Imaging"},{"issue":"10","key":"750_CR41","doi-asserted-by":"publisher","first-page":"1022","DOI":"10.1016\/j.jacc.2007.10.049","volume":"51","author":"H Vogelsberg","year":"2008","unstructured":"Vogelsberg H, Mahrholdt H, Deluigi CC, Yilmaz A, Kispert EM, Greulich S, et al. Cardiovascular magnetic resonance in clinically suspected Cardiac Amyloidosis: noninvasive imaging compared to Endomyocardial Biopsy. J Am Coll Cardiol. 2008;51(10):1022\u201330.","journal-title":"J Am Coll Cardiol"},{"issue":"5","key":"750_CR42","doi-asserted-by":"publisher","first-page":"824","DOI":"10.1016\/S0002-8703(98)70127-9","volume":"136","author":"R Fattori","year":"1998","unstructured":"Fattori R, Rocchi G, Celletti F, Bertaccini P, Rapezzi C, Gavelli G. Contribution of magnetic resonance imaging in the differential diagnosis of cardiac amyloidosis and symmetric hypertrophic cardiomyopathy. Am Heart J. 1998;136(5):824\u201330.","journal-title":"Am Heart J"},{"key":"750_CR43","doi-asserted-by":"crossref","unstructured":"Ghadimi DJ, Vahdani AM, Karimi H, Ebrahimi P, Fathi M, Moodi F et al. Deep learning-based techniques in Glioma Brain Tumor Segmentation using multi-parametric MRI: a review on clinical applications and future outlooks. J Magn Reson Imaging. 2024.","DOI":"10.1002\/jmri.29543"},{"issue":"12","key":"750_CR44","doi-asserted-by":"publisher","first-page":"2260","DOI":"10.1016\/j.jacc.2004.03.035","volume":"43","author":"JC Moon","year":"2004","unstructured":"Moon JC, Reed E, Sheppard MN, Elkington AG, Ho S, Burke M, et al. The histologic basis of late gadolinium enhancement cardiovascular magnetic resonance in hypertrophic cardiomyopathy. J Am Coll Cardiol. 2004;43(12):2260\u20134.","journal-title":"J Am Coll Cardiol"},{"issue":"2","key":"750_CR45","doi-asserted-by":"publisher","first-page":"186","DOI":"10.1161\/01.CIR.0000152819.97857.9D","volume":"111","author":"AM Maceira","year":"2005","unstructured":"Maceira AM, Joshi J, Prasad SK, Moon JC, Perugini E, Harding I, et al. Cardiovascular magnetic resonance in Cardiac Amyloidosis. Circulation. 2005;111(2):186\u201393.","journal-title":"Circulation"},{"issue":"4","key":"750_CR46","doi-asserted-by":"publisher","first-page":"488","DOI":"10.1016\/j.jcmg.2012.11.013","volume":"6","author":"TD Karamitsos","year":"2013","unstructured":"Karamitsos TD, Piechnik SK, Banypersad SM, Fontana M, Ntusi NB, Ferreira VM, et al. Noncontrast T1 mapping for the diagnosis of cardiac amyloidosis. JACC Cardiovasc Imaging. 2013;6(4):488\u201397.","journal-title":"JACC Cardiovasc Imaging"},{"key":"750_CR47","doi-asserted-by":"crossref","unstructured":"Li W, Uppal D, Wang YC, Xu X, Kokkinidis DG, Travin MI, Tauras JM. Nuclear Imaging for the diagnosis of Cardiac Amyloidosis in 2021. Diagnostics (Basel). 2021;11(6).","DOI":"10.3390\/diagnostics11060996"},{"issue":"5","key":"750_CR48","doi-asserted-by":"publisher","first-page":"395","DOI":"10.1042\/CS20160413","volume":"131","author":"NJ Galant","year":"2017","unstructured":"Galant NJ, Westermark P, Higaki JN, Chakrabartty A. Transthyretin amyloidosis: an under-recognized neuropathy and cardiomyopathy. Clin Sci (Lond). 2017;131(5):395\u2013409.","journal-title":"Clin Sci (Lond)"},{"issue":"1","key":"750_CR49","doi-asserted-by":"publisher","first-page":"221","DOI":"10.1186\/s12872-018-0952-8","volume":"18","author":"P Kyriakou","year":"2018","unstructured":"Kyriakou P, Mouselimis D, Tsarouchas A, Rigopoulos A, Bakogiannis C, Noutsias M, Vassilikos V. Diagnosis of cardiac amyloidosis: a systematic review on the role of imaging and biomarkers. BMC Cardiovasc Disord. 2018;18(1):221.","journal-title":"BMC Cardiovasc Disord"},{"issue":"7","key":"750_CR50","doi-asserted-by":"publisher","first-page":"1133","DOI":"10.1038\/aps.2018.38","volume":"39","author":"M Luciani","year":"2018","unstructured":"Luciani M, Troncone L, Monte FD. Current and future circulating biomarkers for cardiac amyloidosis. Acta Pharmacol Sin. 2018;39(7):1133\u201341.","journal-title":"Acta Pharmacol Sin"},{"issue":"7","key":"750_CR51","doi-asserted-by":"publisher","first-page":"46","DOI":"10.1007\/s11912-017-0607-4","volume":"19","author":"M Tuzovic","year":"2017","unstructured":"Tuzovic M, Yang EH, Baas AS, Depasquale EC, Deng MC, Cruz D, Vorobiof G. Cardiac amyloidosis: diagnosis and treatment strategies. Curr Oncol Rep. 2017;19(7):46.","journal-title":"Curr Oncol Rep"},{"issue":"3","key":"750_CR52","doi-asserted-by":"publisher","first-page":"969","DOI":"10.1378\/chest.124.3.969","volume":"124","author":"JL Berk","year":"2003","unstructured":"Berk JL, Keane J, Seldin DC, Sanchorawala V, Koyama J, Dember LM, Falk RH. Persistent pleural effusions in primary systemic amyloidosis: etiology and prognosis. Chest. 2003;124(3):969\u201377.","journal-title":"Chest"},{"issue":"3","key":"750_CR53","first-page":"414","volume":"2","author":"RK Cheng","year":"2020","unstructured":"Cheng RK, Levy WC, Vasbinder A, Teruya S, De Los Santos J, Leedy D, Maurer MS. Diuretic dose and NYHA Functional Class are independent predictors of mortality in patients with Transthyretin Cardiac Amyloidosis. JACC: CardioOncology. 2020;2(3):414\u201324.","journal-title":"JACC: CardioOncology"},{"issue":"13","key":"750_CR54","doi-asserted-by":"publisher","first-page":"1645","DOI":"10.1016\/0002-9149(85)90995-6","volume":"55","author":"MA Gertz","year":"1985","unstructured":"Gertz MA, Falk RH, Skinner M, Cohen AS, Kyle RA. Worsening of congestive heart failure in amyloid heart disease treated by calcium channel-blocking agents. Am J Cardiol. 1985;55(13):1645.","journal-title":"Am J Cardiol"},{"issue":"6","key":"750_CR55","doi-asserted-by":"publisher","first-page":"1285","DOI":"10.1161\/01.CIR.63.6.1285","volume":"63","author":"A Rubinow","year":"1981","unstructured":"Rubinow A, Skinner M, Cohen AS. Digoxin sensitivity in amyloid cardiomyopathy. Circulation. 1981;63(6):1285\u20138.","journal-title":"Circulation"},{"key":"750_CR56","doi-asserted-by":"crossref","unstructured":"Laptseva N, Rossi VA, Sudano I, Schwotzer R, Ruschitzka F, Flammer AJ, Duru F. Arrhythmic manifestations of Cardiac Amyloidosis: challenges in Risk Stratification and Clinical Management. J Clin Med. 2023;12(7).","DOI":"10.3390\/jcm12072581"},{"issue":"10","key":"750_CR57","doi-asserted-by":"publisher","first-page":"1415","DOI":"10.3324\/haematol.11413","volume":"92","author":"AG Morie","year":"2007","unstructured":"Morie AG, Martha QL, Angela D, Suzanne RH, Shaji KK, Nelson L, Dennis AG. Effect of hematologic response on outcome of patients undergoing transplantation for primary amyloidosis: importance of achieving a complete response. Haematologica. 2007;92(10):1415\u20138.","journal-title":"Haematologica"},{"issue":"4","key":"750_CR58","doi-asserted-by":"publisher","first-page":"431","DOI":"10.1161\/CIRCULATIONAHA.118.035831","volume":"139","author":"SD Solomon","year":"2019","unstructured":"Solomon SD, Adams D, Kristen A, Grogan M, Gonz\u00e1lez-Duarte A, Maurer MS, et al. Effects of Patisiran, an RNA interference therapeutic, on Cardiac parameters in patients with Hereditary transthyretin-mediated amyloidosis. Circulation. 2019;139(4):431\u201343.","journal-title":"Circulation"},{"issue":"3","key":"750_CR59","doi-asserted-by":"publisher","first-page":"319","DOI":"10.1111\/bjh.16059","volume":"187","author":"EM Boyle","year":"2019","unstructured":"Boyle EM, Leleu X, Petillon MO, Karlin L, Doyen C, Demarquette H, et al. Daratumumab and dexamethasone is safe and effective for triple refractory myeloma patients: final results of the IFM 2014-04 (Etoile Du Nord) trial. Br J Haematol. 2019;187(3):319\u201327.","journal-title":"Br J Haematol"},{"key":"750_CR60","doi-asserted-by":"crossref","unstructured":"Gertz MA, Comenzo R, Falk RH, Fermand JP, Hazenberg BP, Hawkins PN et al. Definition of organ involvement and treatment response in immunoglobulin light chain amyloidosis (AL): a consensus opinion from the 10th International Symposium on Amyloid and Amyloidosis, Tours, France, 18\u201322 April 2004. Am J Hematol. 2005;79(4):319\u2009\u2013\u200928.","DOI":"10.1002\/ajh.20381"}],"container-title":["International Journal of Emergency Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12245-024-00750-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12245-024-00750-x\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12245-024-00750-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,10,21]],"date-time":"2024-10-21T12:02:50Z","timestamp":1729512170000},"score":1,"resource":{"primary":{"URL":"https:\/\/intjem.biomedcentral.com\/articles\/10.1186\/s12245-024-00750-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,10,21]]},"references-count":60,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2024,12]]}},"alternative-id":["750"],"URL":"https:\/\/doi.org\/10.1186\/s12245-024-00750-x","relation":{},"ISSN":["1865-1380"],"issn-type":[{"value":"1865-1380","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,10,21]]},"assertion":[{"value":"23 July 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"9 October 2024","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"21 October 2024","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}},{"value":"The patient provided written informed consent to participate in this clinical case report, ensuring that all personal information and medical data will be kept confidential and used solely for research purposes.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent to participate"}},{"value":"The patient provided informed consent for the publication of this report, and the center\u2019s ethical policy performed the procedure.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":5,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"159"}}